Medication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.

Plain English Breakdown

The bill text provided does not match the summary and digest. The bill text focuses on making available a list of gluten-containing products by the Department of Health, while the summary and digest focus on ingredient labeling study.

Medication and Vaccine Ingredient Labeling Study

This bill directs the Board of Pharmacy to form a work group that will study ingredient labeling for medications, drugs, and vaccines in Virginia.

What This Bill Does

• Directs the Board of Pharmacy to convene a work group to review regulations related to medication, drug, and vaccine ingredient labeling.
• Ensures all active and inactive ingredients are clearly listed on product packaging or informational inserts.
• Studies the feasibility of requiring gluten-containing products to have a statement about it on their labels.
• Requires the work group to report its findings and recommendations by December 1, 2026.

Who It Names or Affects

• The Board of Pharmacy
• Pharmacies that sell or distribute medications, drugs, or vaccines in Virginia

Terms To Know

Work group

A team created to study a specific topic and make recommendations.

Inactive ingredients

Ingredients in medications that do not affect the body but are used for other purposes like making the pill easier to swallow or preserving it.

Limits and Unknowns

• The bill does not specify what actions will be taken based on the work group's report.
• It only requires a list of products containing gluten by December 1, 2026, but does not detail how this information should be used.

Official Summary Text

Board of Pharmacy; work group to study medication, drug, and vaccine ingredient labeling; report.
Directs the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling. The bill directs the work group to review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (i) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (ii) accompanying informational inserts are readily available to consumers at a pharmacy upon request. The bill also directs the work group to study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The bill requires the work group to report its findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.

Current Bill Text

HOUSE BILL NO. 831

AMENDMENT IN THE NATURE OF A SUBSTITUTE

(Proposed by the House Committee on Rules

on ________________)

(Patron Prior to Substitute--Delegate Kent)

A BILL to direct the Department of Health to make available on its website a list of medications, drugs, or vaccines that include gluten.

Be it enacted by the General Assembly of Virginia:

1.
§ 1.
That the
Department of Health (the Department) shall

make
publicly
available on its website
a list of any

medication
s
, drug
s
, or vaccine
s commonly
sold or distributed in the Commonwealth that include gluten as an active or inactive
ingredient
.
The Department shall make such information available by December
1, 2026.